Multidrug-resistant tuberculosis in europe, 2010-2011

G. Günther, F. Van Leth, S. Alexandru, N. Altet, K. Avsar, D. Bang, R. Barbuta, G. Bothamley, A. Ciobanu, V. Crudu, M. Danilovits, M. Dedicoat, R. Duarte, G. Gualano, H. Kunst, W. De Lange, V. Leimane, C. Magis-Escurra, A.-M. McLaughlin, I. MuylleV. Polcová, E. Pontali, C. Popa, R. Rumetshofer, A. Skrahina, V. Solodovnikova, V. Spinu, S. Tiberi, P. Viiklepp, C. Lange, M. Rowhani, V. Avchinko, D. Katovich, D. Klimuk, V. Lobik, Z. Rohaya, A. Shirochyn, J. Kotrbova, M. Vasakova, A.B. Andersen, N. Smitsman, R. Mütterlein, S. De Lorenzo, L. Rusmane, A. Donica, I. Cernenco, V. Dubceac, F. Cuppen, I. De Guchtenaire, R. Meesters, M. Te Pas, B. Prins, A. Atunes, D. Gainaru, E. Ibraim, M. Tigau, J. Cayla, L. Fina, M.L. De Souza Galvao, J. Maldonado

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

© 2015, Centers for Disease Control and Prevention (CDC). All rights reserved.Drug-resistant Mycobacterium tuberculosis is challenging elimination of tuberculosis (TB). We evaluated risk factors for TB and levels of second-line drug resistance in M. tuberculosis in patients in Europe with multidrug-resistant (MDR) TB. A total of 380 patients with MDR TB and 376 patients with non-MDR TB were enrolled at 23 centers in 16 countries in Europe during 2010-2011. A total of 52.4% of MDR TB patients had never been treated for TB, which suggests primary transmission of MDR M. tuberculosis. At initiation of treatment for MDR TB, 59.7% of M. tuberculosis strains tested were resistant to pyrazinamide, 51.1% were resistant to >1 second-line drug, 26.6% were resistant to second-line injectable drugs, 17.6% were resistant to fuoroquinolones, and 6.8% were extensively drug resistant. Previous treatment for TB was the strongest risk factor for MDR TB. High levels of primary transmission and advanced resistance to second-line drugs characterize MDR TB cases in Europe.
Original languageEnglish
Pages (from-to)409-416
JournalEmerging Infectious Diseases
Volume21
Issue number3
DOIs
Publication statusPublished - 2015
Externally publishedYes

Fingerprint

Dive into the research topics of 'Multidrug-resistant tuberculosis in europe, 2010-2011'. Together they form a unique fingerprint.

Cite this